Germany, France, Italy and the Netherlands signed an initial deal
with pharmaceutical company AstraZeneca for over 300 million doses of a
promising coronavirus vaccine currently still in the experimental phase,
Germany's health ministry confirmed Saturday.
Doses of the vaccine would be distributed to countries relative to their population as soon as it is ready, the ministry said, adding that all EU members can participate in the program.
The vaccine is expected to be finished by the end of 2020.
Doses of the vaccine would be distributed to countries relative to their population as soon as it is ready, the ministry said, adding that all EU members can participate in the program.
The vaccine is expected to be finished by the end of 2020.
